Research location

Milan

Milano, Italy

Published trials97

Site observations124

Linked trials published95

Page2 / 2

Research activity in Milan

Milano, Italy

CureCurrent currently publishes aggregate city-level research activity for this location: 97 trials and 124 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Milan

95 linked trials · page 2 of 2

A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 DiabetesNCT05433584 · 2022-08-01 · 1 site observation

ACTIVE_NOT_RECRUITING

A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)NCT04819100 · 2021-12-20 · 1 site observation

ACTIVE_NOT_RECRUITING

Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65).NCT05116189 · 2021-12-13 · 1 site observation

ACTIVE_NOT_RECRUITING

A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035)NCT05093933 · 2021-11-02 · 1 site observation

Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11)NCT05008224 · 2021-10-07 · 1 site observation

National Project on Vaccines, COVID-19 and Frail PatientsNCT04848493 · 2021-04-19 · 4 site observations

Preoperative Lymph Node Staging With EBUS-TBNA in Clinical N0 Non Small-cell Lung CancerNCT04828850 · 2021-04-01 · 1 site observation

Predicting Parkinson's Disease Before It Strikes: A Brain Imaging Study in At-Risk IndividualNCT07729748 · 2020-12-04 · 2 site observations

ACTIVE_NOT_RECRUITING

A Study of Oral Upadacitinib Tablets to Assess Treatment Patterns, Achievement of Treatment Targets and Maintenance of Response in Adult Participants With Moderate to Severe Rheumatoid ArthritisNCT04497597 · 2020-10-16 · 2 site observations

A Study of the Efficacy and Safety of Relacorilant in Patients With Cortisol-Secreting Adrenal AdenomasNCT04308590 · 2020-07-27 · 1 site observation

Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)NCT04246177 · 2020-05-22 · 1 site observation

Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)NCT04221945 · 2020-05-12 · 1 site observation

A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung CancerNCT04194944 · 2020-02-17 · 1 site observation

ACTIVE_NOT_RECRUITING

Flexible-Dose Trial in Early Parkinson's Disease (PD)NCT04223193 · 2020-01-06 · 1 site observation

Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast CancerNCT04059484 · 2019-10-22 · 1 site observation

A Study of Baricitinib (LY3009104) in Participants With Rheumatoid ArthritisNCT03915964 · 2019-04-25 · 1 site observation

To Reduce the Use of Chemotherapy in Postmenopausal Patients With ER-positive and HER2-positive Breast Cancer (TOUCH)NCT03644186 · 2019-04-16 · 1 site observation

Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid TumorsNCT03821935 · 2019-02-21 · 1 site observation

ACTIVE_NOT_RECRUITING

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)NCT03711032 · 2018-12-24 · 1 site observation

ACTIVE_NOT_RECRUITING

Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung CancerNCT03539536 · 2018-10-10 · 1 site observation

ACTIVE_NOT_RECRUITING

Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)NCT03425643 · 2018-04-24 · 1 site observation

ACTIVE_NOT_RECRUITING

Phase 1/2 Study of Amcenestrant (SAR439859) Single Agent and in Combination With Other Anti-cancer Therapies in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast CancerNCT03284957 · 2017-09-20 · 1 site observation

Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast CancerNCT03155997 · 2017-07-12 · 1 site observation

ACTIVE_NOT_RECRUITING

SEMEiotic Oriented Technology for Individual's CardiOmetabolic Risk Self- assessmeNt and Self-monitoringNCT02818504 · 2016-07-01 · 1 site observation

Observational Study to Establish Patient-Matched Population Norms for the Multiple Sclerosis Cognition Assessment BatteryNCT02283918 · 2014-11-01 · 1 site observation

Nitric Oxyde Concentration in Chronic Obstructive Pulmonary Disease Patients - SANOB StudyNCT01853787 · 2014-07-01 · 1 site observation

A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast CancerNCT02163694 · 2014-04-08 · 1 site observation

Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's DiseaseNCT01969136 · 2013-10-01 · 1 site observation

Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's DiseaseNCT01969123 · 2013-10-01 · 1 site observation

Clinical Study for Adaptive Deep Brain Stimulation (aDBS)Controlled by Intracerebral Activity in Parkinson's DiseaseNCT02154724 · 2013-09-01 · 1 site observation

A 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic TherapyNCT01714713 · 2013-06-01 · 1 site observation

Effects of Greenselect Phytosome® on Weight Maintenance After Weight Loss in Obese WomenNCT02542449 · 2013-04-01 · 1 site observation

Re-boosting of HIV-1 Infected Subjects With Vacc-4xNCT01712256 · 2012-12-01 · 1 site observation

Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular DiseaseNCT01609582 · 2012-06-01 · 1 site observation

Comparison of Fasiglifam (TAK-875) to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 DiabetesNCT01549964 · 2012-04-01 · 1 site observation

Effect of Prolonged Decubitus on Nitric Oxide Concentration in Chronic Obstructive Pulmonary DiseaseNCT01555593 · 2012-03-01 · 1 site observation

A Study to Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil AloneNCT01456169 · 2011-10-01 · 1 site observation

Closing Volume Interpretation and Bronchodilators EffectNCT01437748 · 2011-08-01 · 1 site observation

SPHERIC-1. Sildenafil and Pulmonary HypERtension In COPDNCT01441934 · 2010-10-01 · 1 site observation

Overcoming Endocrine Resistance in Metastatic Breast CancerNCT02394496 · 2007-11-01 · 1 site observation

Trastuzumab Optimization Trial in Breast CancerNCT00637325 · 2007-11-01 · 2 site observations

Tarceva Italian Lung Optimization tRialNCT00637910 · 2007-11-01 · 5 site observations

Blood Pressure Control and Compliance to Treatment in Hypertensive Patients With Metabolic Syndrome: a Study Based on Home Blood Pressure Telemonitoring and Assessment of Psychological DeterminantsNCT01541566 · 2007-11-01 · 1 site observation

The Effects of Bindarit in Diabetic NephropathyNCT01109212 · 2007-03-01 · 1 site observation

Axillary Dissection Based on the Histological Result of the Sentinel Node, in Patients With Breast CarcinomaNCT00970983 · 1998-03-01 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.